We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current STIM market cap is 41.88M. The company's latest EPS is USD -0.9948 and P/E is -1.33.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 17.88M | 20.31M | 17.42M | 16.45M | 18.53M |
| Operating Income | -8.87M | -4.43M | -6.86M | -8.51M | -7.73M |
| Net Income | -9.39M | -5.38M | -7.87M | -9.83M | -13.34M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 62.66M | 49.24M | 55.31M | 65.21M | 71.35M |
| Operating Income | -26.93M | -22.31M | -27.56M | -35.11M | -30.55M |
| Net Income | -29.04M | -27.45M | -31.19M | -37.16M | -30.19M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 92.99M | 115.83M | 103.81M | 96.81M | 74.12M |
| Total Liabilities | 55.05M | 81.64M | 76.16M | 77.43M | 64.74M |
| Total Equity | 37.94M | 34.19M | 27.66M | 19.39M | 9.38M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 100.17M | 78.66M | 141.22M | 116.88M | 115.83M |
| Total Liabilities | 52.32M | 53.16M | 56.05M | 59.82M | 81.64M |
| Total Equity | 47.85M | 25.49M | 85.18M | 57.06M | 34.19M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -34.17M | -32.04M | -12.02M | -16.98M | -22.4M |
| Investing | -759k | -1.32M | 68k | -51k | -37k |
| Financing | 437k | 22.7M | N/A | N/A | -16.37M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -30.48M | -28.39M | -27.98M | -30.74M | -32.04M |
| Investing | -813k | -730k | -9.84M | 6.73M | -1.32M |
| Financing | 2.42M | 2.37M | 83.01M | 207k | 22.7M |
| Market Cap | 41.88M |
| Price to Earnings Ratio | -1.33 |
| Price to Sales Ratio | 0.56 |
| Price to Cash Ratio | 0.67 |
| Price to Book Ratio | 1.17 |
| Dividend Yield | - |
| Shares Outstanding | 30.35M |
| Average Volume (1 week) | 295.47k |
| Average Volume (1 Month) | 251.13k |
| 52 Week Change | -51.75% |
| 52 Week High | 5.0699 |
| 52 Week Low | 0.52 |
| Spread (Intraday) | 0.26 (17.22%) |
| Company Name | Neuronetics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.neurostar.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
